Source: Eur Respir J 2009; 34: 184-190
Disease area: Respiratory infections, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Liu G-N. , Shi H-Z. , Xie Z-H. , Shen H-H. , Huang H-Q. , Deng J-M. , Liang Q-L. , Wu Y-B.. Epithelial neutrophil-activating peptide-78 recruits neutrophils into pleural effusion. Eur Respir J 2009; 34: 184-190

Member's Comments

No comment yet.

Related content which might interest you: Tumor-derived monocyte chemoattractant protein-1 promotes malignant pleural effusion Source: Eur Respir J 2007; 30: Suppl. 51, 290s Year: 2007 Pleural LTB4 upregulates ICAM-1 molecules via STAT-1 activation on pleural mesothelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 718s Year: 2004 Mast cells recruitment to malignant pleural effusions Source: Annual Congress 2010 - Current issues in malignant pleural diseases Year: 2010 Interleukin-8 activates coagulation and correlates with survival after talc pleurodesis Source: Eur Respir J 2010; 35: 160-166 Year: 2010 IL-8 production and gene expression in pleural fluid and blood after talc pleurodesis Source: Annual Congress 2006 - New developments in diagnostic and therapeutic bronchoscopy and thoracoscopy Year: 2006 Characterisation of pleural inflammation occurring after primary spontaneous pneumothorax Source: Eur Respir J 2004; 23: 896-900 Year: 2004 Evidence that mesothelial cells regulate the acute inflammatory response in talc pleurodesis Source: Eur Respir J 2006; 28: 929-932 Year: 2006 Interleukin-16 in tuberculous and malignant pleural effusions Source: Eur Respir J 2005; 25: 605-611 Year: 2005 Interleukin-8 and other mediators are related to tumour burden in malignant pleural effusions (MPE) Source: Eur Respir J 2007; 30: Suppl. 51, 103s Year: 2007 Comparison in effectiveness and proinflammatory mediators between talc, doxycycline and tetracycline for pleurodesis in malignant pleural effusions (MPE) Source: Annual Congress 2006 - New developments in diagnostic and therapeutic bronchoscopy and thoracoscopy Year: 2006 The role of monocyte chemoattractant protein-1 (MCP-1) in the development of malignant pleural effusion Source: Virtual Congress 2021 – Novel insights into the diagnosis, mechanism and treatment of malignant pleural disease Year: 2021 Non-classical monocytes potentiates the pathogenesis of malignant pleural effusion via the production of IL-1ß Source: International Congress 2019 – Biology of lung cancer Year: 2019 Interelukin-17A is elevated in parapneumonic pleural effusions and is associated with neutrophils and VEGF Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006 Immunological mechanisms in pleural disease Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=50 Year: 2002 Immunological mechanisms in pleural disease Source: Eur Respir J 2003; 21: 539-544 Year: 2003 Biomarkers of infection for the differential diagnosis of pleural effusions Source: Eur Respir J 2009; 34: 1383-1389 Year: 2009 Talc mediates angiostasis in malignant pleural effusions via endostatin induction Source: Eur Respir J 2007; 29: 761-769 Year: 2007 Incidence and aetiology of eosinophilic pleural effusion Source: Eur Respir J 2009; 34: 1111-1117 Year: 2009 Eotaxin and monocyte chemoattractant protein-1 in chronic eosinophilic pneumonia Source: Eur Respir J 2001; 17: 962-968 Year: 2001 Host-derived osteopontin is important for malignant pleural effusion formation Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008